BACKGROUND: X-linked dystonia-parkinsonism is a rare neurological disease endemic to the Philippines. Dystonic symptoms appear in males at the mean age of 40 years and progress to parkinsonism with degenerative pathology in the striatum. A retrotransposon inserted in intron 32 of the TAF1 gene leads to alternative splicing in the region and a reduction of the full-length mRNA transcript. OBJECTIVES: The objective of this study was to discover cell-based and biofluid-based biomarkers for X-linked dystonia-parkinsonism. METHODS: RNA from patient-derived neural progenitor cells and their secreted extracellular vesicles were used to screen for dysregulation of TAF1 expression. Droplet-digital polymerase chain reaction was used to quantify the expression of TAF1 mRNA fragments 5' and 3' to the retrotransposon insertion and the disease-specific splice variant TAF1-32i in whole-blood RNA. Plasma levels of neurofilament light chain were measured using single-molecule array. RESULTS: In neural progenitor cells and their extracellular vesicles, we confirmed that the TAF1-3'/5' ratio was lower in patient samples, whereas TAF1-32i expression is higher relative to controls. In whole-blood RNA, both TAF1-3'/5' ratio and TAF1-32i expression can differentiate patient (n = 44) from control samples (n = 18) with high accuracy. Neurofilament light chain plasma levels were significantly elevated in patients (n = 43) compared with both carriers (n = 16) and controls (n = 21), with area under the curve of 0.79. CONCLUSIONS: TAF1 dysregulation in blood serves as a disease-specific biomarker that could be used as a readout for monitoring therapies targeting TAF1 splicing. Neurofilament light chain could be used in monitoring neurodegeneration and disease progression in patients.
BACKGROUND: X-linked dystonia-parkinsonism is a rare neurological disease endemic to the Philippines. Dystonic symptoms appear in males at the mean age of 40 years and progress to parkinsonism with degenerative pathology in the striatum. A retrotransposon inserted in intron 32 of the TAF1 gene leads to alternative splicing in the region and a reduction of the full-length mRNA transcript. OBJECTIVES: The objective of this study was to discover cell-based and biofluid-based biomarkers for X-linked dystonia-parkinsonism. METHODS: RNA from patient-derived neural progenitor cells and their secreted extracellular vesicles were used to screen for dysregulation of TAF1 expression. Droplet-digital polymerase chain reaction was used to quantify the expression of TAF1 mRNA fragments 5' and 3' to the retrotransposon insertion and the disease-specific splice variant TAF1-32i in whole-blood RNA. Plasma levels of neurofilament light chain were measured using single-molecule array. RESULTS: In neural progenitor cells and their extracellular vesicles, we confirmed that the TAF1-3'/5' ratio was lower in patient samples, whereas TAF1-32i expression is higher relative to controls. In whole-blood RNA, both TAF1-3'/5' ratio and TAF1-32i expression can differentiate patient (n = 44) from control samples (n = 18) with high accuracy. Neurofilament light chain plasma levels were significantly elevated in patients (n = 43) compared with both carriers (n = 16) and controls (n = 21), with area under the curve of 0.79. CONCLUSIONS: TAF1 dysregulation in blood serves as a disease-specific biomarker that could be used as a readout for monitoring therapies targeting TAF1 splicing. Neurofilament light chain could be used in monitoring neurodegeneration and disease progression in patients.
Authors: Yakeel T Quiroz; Henrik Zetterberg; Eric M Reiman; Yinghua Chen; Yi Su; Joshua T Fox-Fuller; Gloria Garcia; Andres Villegas; Diego Sepulveda-Falla; Marina Villada; Joseph F Arboleda-Velasquez; Edmarie Guzmán-Vélez; Clara Vila-Castelar; Brian A Gordon; Stephanie A Schultz; Hillary D Protas; Valentina Ghisays; Margarita Giraldo; Victoria Tirado; Ana Baena; Claudia Munoz; Silvia Rios-Romenets; Pierre N Tariot; Kaj Blennow; Francisco Lopera Journal: Lancet Neurol Date: 2020-05-26 Impact factor: 44.182
Authors: Virgilio Gerald H Evidente; Dagmar Nolte; Stephan Niemann; Joel Advincula; Mezzanie C Mayo; Filipinas F Natividad; Ulrich Müller Journal: Arch Neurol Date: 2004-12
Authors: Michael Khalil; Charlotte E Teunissen; Markus Otto; Fredrik Piehl; Maria Pia Sormani; Thomas Gattringer; Christian Barro; Ludwig Kappos; Manuel Comabella; Franz Fazekas; Axel Petzold; Kaj Blennow; Henrik Zetterberg; Jens Kuhle Journal: Nat Rev Neurol Date: 2018-10 Impact factor: 42.937
Authors: Aloysius Domingo; Ana Westenberger; Lillian V Lee; Ingrid Brænne; Tian Liu; Inga Vater; Raymond Rosales; Roland Dominic Jamora; Paul Matthew Pasco; Eva Maria Cutiongco-Dela Paz; Karen Freimann; Thomas Gpm Schmidt; Dirk Dressler; Frank J Kaiser; Lars Bertram; Jeanette Erdmann; Katja Lohmann; Christine Klein Journal: Eur J Hum Genet Date: 2015-01-21 Impact factor: 4.246
Authors: Saumya Das; K Mark Ansel; Markus Bitzer; Xandra O Breakefield; Alain Charest; David J Galas; Mark B Gerstein; Mihir Gupta; Aleksandar Milosavljevic; Michael T McManus; Tushar Patel; Robert L Raffai; Joel Rozowsky; Matthew E Roth; Julie A Saugstad; Kendall Van Keuren-Jensen; Alissa M Weaver; Louise C Laurent Journal: Cell Date: 2019-04-04 Impact factor: 66.850
Authors: Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield Journal: Nat Cell Biol Date: 2008-11-16 Impact factor: 28.824
Authors: Morgan Chandler; Brittany Johnson; Emil Khisamutdinov; Marina A Dobrovolskaia; Joanna Sztuba-Solinska; Aliasger K Salem; Koen Breyne; Roger Chammas; Nils G Walter; Lydia M Contreras; Peixuan Guo; Kirill A Afonin Journal: ACS Nano Date: 2021-10-22 Impact factor: 18.027
Authors: Jelena Pozojevic; Shela Marie Algodon; Joseph Neos Cruz; Joanne Trinh; Norbert Brüggemann; Joshua Laß; Karen Grütz; Susen Schaake; Ronnie Tse; Veronica Yumiceba; Nathalie Kruse; Kristin Schulz; Varun K A Sreenivasan; Raymond L Rosales; Roland Dominic G Jamora; Cid Czarina E Diesta; Jakob Matschke; Markus Glatzel; Philip Seibler; Kristian Händler; Aleksandar Rakovic; Henriette Kirchner; Malte Spielmann; Frank J Kaiser; Christine Klein; Ana Westenberger Journal: Int J Mol Sci Date: 2022-02-17 Impact factor: 5.923
Authors: Lindsey N Campion; Alan Mejia Maza; Rachita Yadav; Ellen B Penney; Micaela G Murcar; Kevin Correia; Tammy Gillis; Cara Fernandez-Cerado; M Salvie Velasco-Andrada; G Paul Legarda; Niecy G Ganza-Bautista; J Benedict B Lagarde; Patrick J Acuña; Trisha Multhaupt-Buell; Gabrielle Aldykiewicz; Melanie L Supnet; Jan K De Guzman; Criscely Go; Nutan Sharma; Edwin L Munoz; Mark C Ang; Cid Czarina E Diesta; D Cristopher Bragg; Laurie J Ozelius; Vanessa C Wheeler Journal: Acta Neuropathol Commun Date: 2022-04-08 Impact factor: 7.801
Authors: Laura D'Ignazio; Ricardo S Jacomini; Bareera Qamar; Kynon J M Benjamin; Ria Arora; Tomoyo Sawada; Taylor A Evans; Kenneth E Diffenderfer; Aimee R Pankonin; William T Hendriks; Thomas M Hyde; Joel E Kleinman; Daniel R Weinberger; D Cristopher Bragg; Apua C M Paquola; Jennifer A Erwin Journal: eNeuro Date: 2022-07-21